Intracranial Stenting Using a Drug-Eluting Stent for Moyamoya Disease Involving Supraclinoid Internal Carotid Artery: A Case Report

[Abstract] A 43-year-old woman was diagnosed with moyamoya disease (MMD) and underwent right-side bypass surgery. After surgery, previous symptoms disappeared. One month later, transient right hemiparetic attacks and motor dysphasia developed. Angiography revealed progressive severe stenosis of left...

Full description

Saved in:
Bibliographic Details
Published inNeurologia medico-chirurgica Vol. 54; no. 2; pp. 136 - 138
Main Authors KIM, Tackeun, KWON, O-Ki, OH, Chang Wan, BANG, Jae Seung, HWANG, Gyojun, LEE, Young-Jin
Format Journal Article
LanguageEnglish
Published THE JAPAN NEUROSURGICAL SOCIETY 01.02.2014
The Japan Neurosurgical Society
Subjects
Case Report
Online AccessGet full text

Cover

More Information
Summary:[Abstract] A 43-year-old woman was diagnosed with moyamoya disease (MMD) and underwent right-side bypass surgery. After surgery, previous symptoms disappeared. One month later, transient right hemiparetic attacks and motor dysphasia developed. Angiography revealed progressive severe stenosis of left supraclinoid segment of internal carotid artery. Angioplasty using a drug-eluting stent (DES) was performed. For 18 months, she presented no ischemic symptom and no in-stent stenosis was observed in follow-up angiography. This is the first case report about effect of DES use for MMD. Considering that intimal hyperplasia is a pathophysiology of stenosis, DES may have a role in reducing progression of stenosis in selected moyamoya patients.
Bibliography:None.
Conflicts of Interest Disclosure
ISSN:0470-8105
1349-8029
DOI:10.2176/nmc.cr2012-0272